• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌中的炎症微环境:肿瘤相关巨噬细胞的关键作用。

The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages.

机构信息

Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, 67100 L'Aquila, Italy.

出版信息

Biomed Res Int. 2013;2013:187204. doi: 10.1155/2013/187204. Epub 2012 Dec 30.

DOI:10.1155/2013/187204
PMID:23533994
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3591180/
Abstract

Hepatocellular carcinoma (HCC) is one of the most common and aggressive human cancers worldwide. HCC is an example of inflammation-related cancer and represents a paradigm of the relation occurring between tumor microenvironment and tumor development. Tumor-associated macrophages (TAMs) are a major component of leukocyte infiltrate of tumors and play a pivotal role in tumor progression of inflammation-related cancer, including HCC. Several studies indicate that, in the tumor microenvironment, TAMs acquire an M2-polarized phenotype and promote angiogenesis, metastasis, and suppression of adaptive immunity through the expression of cytokines, chemokines, growth factors, and matrix metalloproteases. Indeed, an established M2 macrophage population has been associated with poor prognosis in HCC. The molecular links that connect cancer cells and TAMs are not completely known, but recent studies have demonstrated that NF-κB, STAT-3, and HIF-1 signaling pathways play key roles in this crosstalk. In this paper, we discuss the current knowledge about the role of TAMs in HCC development, highlighting the role of TAM-derived cytokines, chemokines, and growth factors in the initiation and progression of liver cancer and outlining the signaling pathways involved in the interplay between cancer cells and TAMs.

摘要

肝细胞癌(HCC)是全球最常见和侵袭性最强的人类癌症之一。HCC 是炎症相关癌症的一个例子,代表了肿瘤微环境与肿瘤发展之间发生的关系的范例。肿瘤相关巨噬细胞(TAMs)是肿瘤白细胞浸润的主要组成部分,在炎症相关癌症(包括 HCC)的肿瘤进展中发挥着关键作用。几项研究表明,在肿瘤微环境中,TAMs 获得 M2 极化表型,并通过表达细胞因子、趋化因子、生长因子和基质金属蛋白酶促进血管生成、转移和适应性免疫抑制。事实上,已确定的 M2 巨噬细胞群体与 HCC 的预后不良有关。连接癌细胞和 TAMs 的分子联系尚不完全清楚,但最近的研究表明,NF-κB、STAT-3 和 HIF-1 信号通路在这种串扰中发挥关键作用。在本文中,我们讨论了 TAMs 在 HCC 发展中的作用的现有知识,强调了 TAM 衍生的细胞因子、趋化因子和生长因子在肝癌的发生和进展中的作用,并概述了涉及癌细胞和 TAMs 相互作用的信号通路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685d/3591180/471f0f34d48f/BMRI2013-187204.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685d/3591180/2af67e0c7801/BMRI2013-187204.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685d/3591180/e624cd5926a8/BMRI2013-187204.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685d/3591180/471f0f34d48f/BMRI2013-187204.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685d/3591180/2af67e0c7801/BMRI2013-187204.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685d/3591180/e624cd5926a8/BMRI2013-187204.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/685d/3591180/471f0f34d48f/BMRI2013-187204.003.jpg

相似文献

1
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages.肝细胞癌中的炎症微环境:肿瘤相关巨噬细胞的关键作用。
Biomed Res Int. 2013;2013:187204. doi: 10.1155/2013/187204. Epub 2012 Dec 30.
2
Crosstalk between hepatic tumor cells and macrophages via Wnt/β-catenin signaling promotes M2-like macrophage polarization and reinforces tumor malignant behaviors.肝肿瘤细胞与巨噬细胞间通过 Wnt/β-catenin 信号通路的串扰促进 M2 样巨噬细胞极化并增强肿瘤恶性行为。
Cell Death Dis. 2018 Jul 18;9(8):793. doi: 10.1038/s41419-018-0818-0.
3
miR-125a/b inhibits tumor-associated macrophages mediated in cancer stem cells of hepatocellular carcinoma by targeting CD90.miR-125a/b 通过靶向 CD90 抑制肿瘤相关巨噬细胞介导的肝癌肿瘤干细胞。
J Cell Biochem. 2019 Mar;120(3):3046-3055. doi: 10.1002/jcb.27436. Epub 2018 Dec 9.
4
Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma.肿瘤相关巨噬细胞通过转化生长因子-β1 诱导的上皮-间充质转化促进肝癌中的癌症干细胞样特性。
Cancer Lett. 2014 Oct 1;352(2):160-8. doi: 10.1016/j.canlet.2014.05.008. Epub 2014 Jun 2.
5
Promotion of epithelial-mesenchymal transformation by hepatocellular carcinoma-educated macrophages through Wnt2b/β-catenin/c-Myc signaling and reprogramming glycolysis.肝癌来源的巨噬细胞通过 Wnt2b/β-catenin/c-Myc 信号通路和重编程糖酵解促进上皮间质转化。
J Exp Clin Cancer Res. 2021 Jan 6;40(1):13. doi: 10.1186/s13046-020-01808-3.
6
CD68(+)HLA-DR(+) M1-like macrophages promote motility of HCC cells via NF-κB/FAK pathway.CD68(+)HLA-DR(+) M1 样巨噬细胞通过 NF-κB/FAK 通路促进 HCC 细胞的迁移。
Cancer Lett. 2014 Apr 1;345(1):91-9. doi: 10.1016/j.canlet.2013.11.013. Epub 2013 Dec 11.
7
SIRT4 silencing in tumor-associated macrophages promotes HCC development via PPARδ signalling-mediated alternative activation of macrophages.沉默 SIRT4 可通过 PPARδ 信号转导介导的肿瘤相关巨噬细胞的替代激活促进 HCC 的发展。
J Exp Clin Cancer Res. 2019 Nov 19;38(1):469. doi: 10.1186/s13046-019-1456-9.
8
NOTCH Signaling via WNT Regulates the Proliferation of Alternative, CCR2-Independent Tumor-Associated Macrophages in Hepatocellular Carcinoma.NOTCH 信号通过 WNT 调控肝癌中替代性、CCR2 非依赖的肿瘤相关巨噬细胞的增殖。
Cancer Res. 2019 Aug 15;79(16):4160-4172. doi: 10.1158/0008-5472.CAN-18-1691. Epub 2019 Jul 2.
9
TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells.M2 肿瘤相关巨噬细胞衍生的 TNF-α 通过 Wnt/β-连环蛋白通路促进 SMMC-7721 肝癌细胞上皮-间充质转化和癌症干性。
Exp Cell Res. 2019 May 1;378(1):41-50. doi: 10.1016/j.yexcr.2019.03.005. Epub 2019 Mar 4.
10
Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF‑κB‑mediated alternative polarization of macrophages.RIP140的过表达通过抑制NF-κB介导的巨噬细胞交替极化来抑制肝细胞癌的恶性潜能。
Oncol Rep. 2017 May;37(5):2971-2979. doi: 10.3892/or.2017.5551. Epub 2017 Apr 5.

引用本文的文献

1
Exploring the impact of galectins on liver cancer: From immunopathogenesis to potential targets.探索半乳糖凝集素对肝癌的影响:从免疫发病机制到潜在靶点。
World J Gastroenterol. 2025 Jul 7;31(25):107260. doi: 10.3748/wjg.v31.i25.107260.
2
Nanoparticle-based therapeutic strategies for chronic liver diseases: Advances and insights.基于纳米颗粒的慢性肝病治疗策略:进展与见解
Liver Res. 2025 Apr 12;9(2):104-117. doi: 10.1016/j.livres.2025.04.002. eCollection 2025 Jun.
3
Bridging Immune Evasion and Vascular Dynamics for Novel Therapeutic Frontiers in Hepatocellular Carcinoma.

本文引用的文献

1
Dynamic education of macrophages in different areas of human tumors.人类肿瘤不同区域巨噬细胞的动态教育
Cancer Microenviron. 2012 Dec;5(3):195-201. doi: 10.1007/s12307-012-0113-z. Epub 2012 Jun 14.
2
The tumor microenvironment in hepatocellular carcinoma (review).肝细胞癌的肿瘤微环境(综述)。
Int J Oncol. 2012 Jun;40(6):1733-47. doi: 10.3892/ijo.2012.1408. Epub 2012 Mar 22.
3
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: subset analyses of the phase III Sorafenib Asia-Pacific trial.
肝细胞癌新型治疗前沿:连接免疫逃逸与血管动力学
Cancers (Basel). 2025 May 31;17(11):1860. doi: 10.3390/cancers17111860.
4
Evaluation of immune checkpoint inhibitor-associated hepatotoxic adverse events: A pharmacovigilance analysis based on the FAERS database.免疫检查点抑制剂相关肝毒性不良事件的评估:基于FAERS数据库的药物警戒分析
Int J Immunopathol Pharmacol. 2025 Jan-Dec;39:3946320251343943. doi: 10.1177/03946320251343943. Epub 2025 May 29.
5
Natural killer cells: the immune frontline against circulating tumor cells.自然杀伤细胞:抵御循环肿瘤细胞的免疫前线。
J Exp Clin Cancer Res. 2025 Apr 10;44(1):118. doi: 10.1186/s13046-025-03375-x.
6
The epigenetic basis of hepatocellular carcinoma - mechanisms and potential directions for biomarkers and therapeutics.肝细胞癌的表观遗传基础——生物标志物与治疗方法的机制及潜在方向
Br J Cancer. 2025 Jun;132(10):869-887. doi: 10.1038/s41416-025-02969-8. Epub 2025 Mar 8.
7
Evaluation of Inflammatory Markers as Prognostic Factors in the Treatment of Hepatocellular Carcinoma (HCC) with Degradable Starch Microspheres by Transarterial Chemoembolization (DSM-TACE).评估炎症标志物作为经动脉化疗栓塞术(DSM-TACE)使用可降解淀粉微球治疗肝细胞癌(HCC)的预后因素。
Cancers (Basel). 2025 Feb 14;17(4):647. doi: 10.3390/cancers17040647.
8
Novel insights into the impact of liver inflammatory responses on primary liver cancer development.关于肝脏炎症反应对原发性肝癌发展影响的新见解。
Liver Res. 2023 Feb 3;7(1):26-34. doi: 10.1016/j.livres.2023.01.001. eCollection 2023 Mar.
9
Use of traditional Chinese medicine bezoars and bezoar-containing preparations in hepatocarcinoma.中药牛黄及含牛黄制剂在肝癌中的应用。
World J Gastrointest Oncol. 2024 Dec 15;16(12):4770-4777. doi: 10.4251/wjgo.v16.i12.4770.
10
Glycosyltransferase B4GALNT1 promotes immunosuppression in hepatocellular carcinoma via the HES4-SPP1-TAM/Th2 axis.糖基转移酶 B4GALNT1 通过 HES4-SPP1-TAM/Th2 轴促进肝癌中的免疫抑制。
Mol Biomed. 2024 Dec 1;5(1):65. doi: 10.1186/s43556-024-00231-w.
索拉非尼治疗晚期肝细胞癌患者的疗效和安全性:III 期索拉非尼亚太临床试验的亚组分析。
Eur J Cancer. 2012 Jul;48(10):1452-65. doi: 10.1016/j.ejca.2011.12.006. Epub 2012 Jan 10.
4
High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases.高迁移率族蛋白 B1 激活半胱氨酸蛋白酶-1 并促进肝癌侵袭和转移。
Hepatology. 2012 Jun;55(6):1863-75. doi: 10.1002/hep.25572.
5
Tumor necrosis factor-alpha -308G/A polymorphism and risk of hepatocellular carcinoma in hepatitis C virus-infected patients.肿瘤坏死因子-α -308G/A多态性与丙型肝炎病毒感染患者肝细胞癌风险
Chin J Cancer. 2012 Jan;31(1):29-35. doi: 10.5732/cjc.011.10258. Epub 2011 Dec 23.
6
Modulation of chemotactic and pro-inflammatory activities of endothelial progenitor cells by hepatocellular carcinoma.肝癌对内皮祖细胞趋化和促炎活性的调节。
Cell Signal. 2012 Mar;24(3):779-93. doi: 10.1016/j.cellsig.2011.11.013. Epub 2011 Nov 18.
7
Cancer-promoting tumor-associated macrophages: new vistas and open questions.促进肿瘤发生的肿瘤相关巨噬细胞:新的视角和未解决的问题。
Eur J Immunol. 2011 Sep;41(9):2522-5. doi: 10.1002/eji.201141894.
8
Upregulation of B7-H1 expression is associated with macrophage infiltration in hepatocellular carcinomas.B7-H1 表达上调与肝癌中的巨噬细胞浸润有关。
Cancer Immunol Immunother. 2012 Jan;61(1):101-8. doi: 10.1007/s00262-011-1094-3. Epub 2011 Aug 19.
9
Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 production.重组 VP1,一种 Akt 抑制剂,通过诱导细胞凋亡和调节 CCL2 的产生来抑制肝癌的进展。
PLoS One. 2011;6(8):e23317. doi: 10.1371/journal.pone.0023317. Epub 2011 Aug 3.
10
Role of the microenvironment in hepatocellular carcinoma development and progression.微环境在肝细胞癌发生和进展中的作用。
Cancer Treat Rev. 2012 May;38(3):218-25. doi: 10.1016/j.ctrv.2011.06.010. Epub 2011 Jul 16.